Corporate ethics: the business code of conduct for ethical employees

2003 ◽  
Vol 41 (04) ◽  
pp. 41-2265-41-2265
Keyword(s):  
Code Of Conduct ◽  
Corporate Ethics ◽  
Business Code

The Influence of Collegiate and Corporate Codes of Conduct on Ethics-Related Behavior in the Workplace

1996 ◽  
Vol 6 (4) ◽  
pp. 461-476 ◽  
Author(s):  
Donald L. McCabe ◽  
Linda Klebe Trevino ◽  
Kenneth D. Butterfield
Keyword(s):  
Unethical Behavior ◽  
Codes Of Conduct ◽  
Code Of Conduct ◽  
Empirical Support ◽  
Corporate Ethics ◽  
Honor Code ◽  
Long Term Effects ◽  
Corporate Code ◽  
Corporate Codes Of Conduct

AbstractCodes of conduct are viewed here as a community's attempt to communicate its expectations and standards of ethical behavior. Many organizations are implementing codes, but empirical support for the relationship between such codes and employee conduct is lacking. We investigated the long term effects of a collegiate honor code experience as well as the effects of corporate ethics codes on unethical behavior in the workplace by surveying alumni from an honor code and a non-honor code college who now work in business. We found that self-reported unethical behavior was lower for respondents who work in an organization with a corporate code of conduct and was inversely associated with corporate code implementation strength and embeddedness. Self-reported unethical behavior was also influenced by the interaction of a collegiate honor code experience and corporate code implementation strength.

Force Automotive – breach of code of conduct

2014 ◽  
Vol 4 (2) ◽  
pp. 1-12
Author(s):  
Tanushree Sharma
Keyword(s):  
Learning Outcomes ◽  
Undergraduate Students ◽  
Code Of Conduct ◽  
Vice President ◽  
Organizational Values ◽  
Subject Area ◽  
Corporate Ethics ◽  
Content Type ◽  
New Business ◽  
A Company

Subject area The case highlights the ethical dilemmas people face in various business situations. The case throws light on the causes and consequences of violation and the problems related to enforcement of shared organizational values/code of conduct. Study level/applicability This case can be used in courses on human resource management, OB and corporate ethics and is suitable for the postgraduate and undergraduate students of business schools. Case overview The case narrates the dilemma faced by the Vice President of human resources (VP-HR) of a company when he discovered a major violation of the company's code of conduct by the Vice President of research and development (VP-R&D). The VP-R&D is almost indispensable to the company given his unique expertise and criticality of the new Design Centre which he is spearheading single-handedly. Sacking the VP-R&D has the potential of delaying commissioning of the new centre and putting new business wins in jeopardy. On the other hand, not taking any action may erode employees faith in code of conduct and company values. The VP-HR must decide fast whether and how to take action on gross violation of company's code of conduct. Expected learning outcomes The students will gain understanding of shared organizational values, code of conduct and ethics, know about the causes and consequences of violation of shared values, discover ways to institutionalize shared organizational values and resolve ethical dilemma. Supplementary materials Teaching notes are available for educators only. Please contact your library to gain login details or email [email protected] to request teaching notes.

Managing stakeholders’ influence on embracing business code of conduct and ethics in a local pharmaceutical company

2016 ◽  
Vol 26 (2) ◽  
pp. 261-290 ◽  
Author(s):  
David Katamba ◽  
Cedric Marvin Nkiko ◽  
Consolate Ademson
Keyword(s):  
Data Collection ◽  
Pharmaceutical Company ◽  
Stakeholder Engagement ◽  
Code Of Ethics ◽  
Codes Of Conduct ◽  
Code Of Conduct ◽  
Multiple Stakeholders ◽  
Content Type ◽  
External Stakeholders ◽  
Business Code

Purpose This paper aims to avail a soft approach to embracing the process of creating a business code of conduct and ethics and make it work for a pharmaceutical company [player] which wants to remain relevant before stakeholders and society, amidst escalating inducements to go against the acceptable pharmaceutical behaviour. Design/methodology/approach Data collection was guided by qualitative methodologies. A four stepwise process was followed: data collection at the case company – Kampala Pharmaceutical Industries (KPI), Uganda; validation of data collected at KPI; data collection from external stakeholders of KPI; and re-validation of KPI data based on data collected from external stakeholders. In all this, combination of semi-structured and informal interviews with CEOs, senior staff managers, non-participant observation of ethical related activities plus organizing a stakeholder engagement workshop on business code of conduct and ethics was achieved. This workshop helped document what ought to be an ideal design process to secure stakeholder buy-in of the code of business ethics. A local pharmaceutical company in Uganda, KPI was used, which, for continuous five years since its adoption of the business code of conduct and ethics, registered commercial viability without any record of unethical practices. Triangulation was used to ensure credibility and validity of the results. For data analysis, a three-stepwise process was followed, which helped develop a framework within which the collected data revealed themes which were later analyzed. For generalization of the findings, the “adaptive theory approach” was used. Findings When poorly introduced in an organization, the business code of conduct and ethics can work against the company simply because it will be received with “intentional rebellion” from stakeholders, notably staff. However, when a soft stakeholder engagement and consultative approach is used and followed during the business code of ethics and conduct’s design process, multiple stakeholders feel proud and are much willing to live by the promise spelt out in it. Cited notable benefits of living by the code include reputational enhancement, strategic competitiveness and increased possibilities of wining cross-border cooperation among like-minded pharmaceutical players. In the efforts to reap from the code of ethics, communication was observed as an indispensable activity. Refresher trainings to remind the stakeholders about the promises in the code are also needed as time passes by, otherwise they forget. Needless to say, rewarding those who live an exemplary life in embracing and living by the code was cited as key in sustaining the ethical agenda. Lastly, managing multiple stakeholders influences is a curvilinear fashion and involves back and forth consultations. Practical implications The lessons learnt from KPI can be borrowed and used by both global pharmaceutical players and national/local players, especially those that face challenges living by the promise of their existing codes or those without business code of conduct and ethics. That is, both players can use the suggested process to help participants in their medicine supply chain to come up with working business codes of conduct, as well as guide the stakeholder consultative process which results in stakeholder buy-in. Originality/value For many years, issues surrounding bioethics have dominated priorities of World Health Organization (WHO), UNESCO and many international and national development allies. However, there is an escalating violation of medical codes of conduct and ethics. Hence, this publication is a step toward the implementation of the principles and objectives of the UNESCO Universal Declaration on Bioethics and Human Rights which is currently challenged with a difficult question posed by life sciences – How far can we go given the dented medical relationship between ethics, medical science and freedom?

EU-Kommission: Empfehlung zu Informationspflichten bei wohnungswirtschaftlichen Darlehen

2001 ◽  
Vol 13 (2) ◽  
Keyword(s):  
Code Of Conduct ◽  
Soft Law

Der Hypothekarkredit zu wohnungswirtschaftlichen Zwecken hat zweifelsohne das Gepräge eines Konsumentenkredits. Aber er ist ein Konsumentenkredit eigener Art: Größe des Kreditvolumens, Langfristigkeit und (zumindest beim pfandbriefrefinanzierten Kredit) Refinanzierungstechnik unterscheiden ihn deutlich von anderen Verbraucherkrediten. Er ist darum nicht Gegenstand der Verbraucherkreditrichtlinie von 1987 gewesen und auch im deutschen Verbraucherkreditgesetz nur ausschnittweise geregelt. Der Entwurf einer eigenen Hypothekarkreditrichtlinie ist schon Anfang der achtziger fahre früh auf der Strecke geblieben.Die nachstehend abgedruckte Empfehlung der Kommission ist die erste Wiederannäherung der EU an die Thematik. Regelungstechnisch handelt es sich um einen von und mit der Kreditwirtschaft ausgehandelten „code of conduct“, der, solange die Realkreditinstitute sich kodexkonform verhalten, den Erlass verbindlicher Rechtsvorschriften erübrigen soll. Die Empfehlung macht damit Ernst mit der im „Aktionsplan Finanzdienstleistungen“ (abgedruckt in: ZBB 1999, 254) verkündeten Absicht, künftig weniger auf schwerfällige und unflexible Richtliniengesetzgebung und stattdessen auf Rahmenregelungen oder auch (wie hier) auf „soft law“ zu setzen, welches mit den beteiligten Wirtschaftskreisen abgestimmt wird. Tradition hat inzwischen auch die Methode, an Stelle der Statuierung materieller Leistungsstandards dem Verbraucher Konditionentransparenz durch vorvertragliche Information zu verschaffen. Im konkreten Detail wird man in den Empfehlungen wenig finden, was nicht entweder zu den Pflichtangaben nach §4 VerbrKrG zählt oder längst schon deutsche AGB-Rechtsprechung zum Hypothekarkredit oder eingebürgerte AGB-Praxis der Realkreditgeber ist. Im Hinblick auf das Risiko vorfälliger Tilgung von Festzinskrediten wird man immerhin begrüßen, daß dem Kreditnehmer die Unterschiede zwischen variablem und Festzinskredit bzw. möglichen Mischformen (Abschnittfinanzierung) klar zu machen und er über die (unter Umständen eingeschränkte) Möglichkeit vorfälliger Tilgung zu informieren ist. Diese Beratung wird den Instituten nicht leichtfallen, falls der Gesetzgeber tatsächlich die verunglückte BGH-Rechtsprechung zu Grund und Grenzen der Vorfälligkeitstilgung im BGB festschreibt (BGH ZIP 1997, 1641 = ZflR 1997, 596 = BGHZ 136, 161, dazu EWiR 1997, 921 (Medicus); jetzt §487 Abs. 2 BGB in der Fassung des „konsolidierten Diskussionsentwurfs“ eines Schuldrechtsmodernisierungsgesetzes vom Februar 2001).

Comprehending and Executing Aacharrasayana in the context of COVID 19

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1099-1104
Author(s):  
Priti Desai ◽  
Anita Wanjari ◽  
Deepali Giri
Keyword(s):  
Preventive Measures ◽  
Code Of Conduct ◽  
Spiritual Health ◽  
Social Health ◽  
Human Being ◽  
Global Level ◽  
Social Distancing ◽  
Global Population

The COVID 19 pandemic had disrupted the lives of all socio-economic groups of the global population. The lockdowns, social distancing, financial adversities, continuous fear of being a victim to the virus had left every individual desperate with a feeling of vulnerability. Irrespective of all possible efforts at the global level, no ultimate solution to get rid of this virus is available till date except for the preventive measures. Various medicines and formulations are into practice, which may boost one’s immunity to fight against the virus. This catastrophic scenario had resulted in an impact on the human being in all aspects, physical, mental, emotional, social and behavioural. Ayurveda, the science of life has encompassed all these aspects through its preventive and curative principles. Aacharrasayana, code of conduct or behavioural discipline is one such modality that entails perfect mental, physical, social and spiritual health of the human being. The execution of Aacharrasayana in this situation can immensely contribute in restoring mental, spiritual and social health. This review aims to interpret the implementation of various aspects of Aacharrasayanain context of COVID 19 and its utility in combatting the dreadful crisis.

Indian Lifestyle With Ayurveda Perspective During Covid-19 Pandemic

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1396-1399
Author(s):  
Disha Bhatero ◽  
Punam Sawarkar ◽  
Gaurav Sawarkar
Keyword(s):  
Infectious Disease ◽  
Disease Resistance ◽  
Prevalence Rate ◽  
Code Of Conduct ◽  
Google Scholar ◽  
Research Articles ◽  
Narrative Form ◽  
Healthy Individuals ◽  
Novel Coronavirus

Covid-19 is an infectious disease caused by novel Coronavirus. The overall prevalence rate of Covid-19 in Worldwide ( 9.94M )& it is (529 K) & (153 K) in India and Maharashtra. This situation can be considered under JanapadodhwansaVyadhi in Ayurveda. The primary purpose of Ayurveda  is the prevention of the disease in healthy individuals and eradication of disease, which are curable. Immunity comes under the Vyadhikshamatva. Further, Covid-19 infection is correlated with Vataj-Kaphaj Jwara. In Ayurveda Rasayana therapy to boost up immunity (Bala  & Vyadhikshamatva). The present study aimed to explore the concept of infectious disease and its prevention through different lifestyles described in Ayurveda. The above need-based information is collected from various Ayurvedicliterature (Laghutrayee, Bruhatryayi) along with numerous research articles from databases, such as PubMed, Google Scholar. All collected data were depicted in narrative form and tabular manner under different heads. Considering the above aspect in the prevention of Covid-19, the role of Ayurveda intervention may be proved more beneficial in Covid-19. Further, adoption of code of conduct may efficiently overcome the current pandemic situation by maintaining good immunity & implementation of Ahar, Vihar Vidhis, Dincharya, and Rutucharya& Sadvritta  for improving disease resistance.

Sign in / Sign up

Export Citation Format

Share Document